Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.500 |
None |
0.955 |
22 |
8
|
2004 |
2018 |
Proline dehydrogenase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2
|
11
|
0.770 |
None |
1.000 |
11 |
10
|
1996 |
2014 |
Hyperprolinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
4
|
3
|
0.170 |
None |
1.000 |
7 |
2
|
2002 |
2014 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
|
2008 |
2019 |
Shprintzen syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
46
|
3
|
0.040 |
None |
1.000 |
4 |
|
2005 |
2016 |
Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2017 |
DiGeorge Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
111
|
7
|
0.030 |
None |
1.000 |
3 |
|
1996 |
2008 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2018 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2008 |
Shprintzen-Goldberg syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
61
|
21
|
0.020 |
None |
1.000 |
2 |
|
1996 |
2005 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2018 |
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
977
|
39
|
0.310 |
None |
1.000 |
2 |
|
2007 |
2013 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2019 |
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1183
|
839
|
0.300 |
None |
0.500 |
2 |
|
2006 |
2006 |
Behavior Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
77
|
4
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2017 |
22q11 Deletion Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
31
|
2
|
0.020 |
None |
1.000 |
2 |
1
|
2008 |
2015 |
Amino acids measurement
|
group |
|
Laboratory Procedure
|
53
|
92
|
0.100 |
None |
1.000 |
2 |
1
|
2015 |
2019 |
Alanine measurement
|
phenotype |
|
Laboratory Procedure
|
3
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Leucine measurement
|
phenotype |
|
Laboratory Procedure
|
2
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.010 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Heparin cofactor II deficiency (disorder)
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
4
|
5
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Tyrosine measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
11
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Contiguous gene syndrome
|
disease |
|
Disease or Syndrome
|
52
|
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.010 |
None |
1.000 |
1 |
1
|
2018 |
2018 |